Human BAFF/BLyS/TNFSF13B Quantikine PharmPak (50 Plates)

• Supplier: R&D Systems
• Catalog: PDBLYS0B
• Category: ELISA Kit
• Assay Type: Solid Phase Sandwich ELISA
• Sample Type: Cell Culture Supernates (25 µL), Serum (25 µL), EDTA Plasma (25 µL), Heparin Plasma (25 µL)
• Sensitivity: 6.44 pg/mL
• Range: 62.5 - 4,000 pg/mL (Serum, Heparin Plasma, Cell Culture Supernates, EDTA Plasma)
• Format: 96-well strip plate
• Description: The Quantikine Human BAFF/BLyS Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human BAFF/BLyS in cell culture supernates, serum, and plasma
• Gene: TNFSF13B

Product References

IFN-beta therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple - IFN-beta therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple

Giacomini E, Severa M, Rizzo F, Mechelli R, Annibali V, Ristori G, Riccieri V, Salvetti M, Coccia EM. Eur J Immunol. 2013 Jul;43(7):1963-72.

IL-15 expression on RA synovial fibroblasts promotes B cell survival. - IL-15 expression on RA synovial fibroblasts promotes B cell survival.

Benito-Miguel M, Garcia-Carmona Y, Balsa A, Bautista-Caro MB, Arroyo-Villa I, Cobo-Ibanez T, Bonilla-Hernan MG, Perez de Ayala C, Sanchez-Mateos P, Martin-Mola E, Miranda-Carus ME. PLoS One. 2012;7(7):e40620.

BAFF levels are increased in lesional skin and sera in patients with cutaneous - BAFF levels are increased in lesional skin and sera in patients with cutaneous

Ohmatsu H, Sugaya M, Miyagaki T, Suga H, Fujita H, Asano Y, Tada Y, Kadono T, Sato S. Br J Dermatol. 2012 Aug;167(2):359-67.

Active chronic sarcoidosis is characterized by increased transitional blood B - Active chronic sarcoidosis is characterized by increased transitional blood B

Saussine A, Tazi A, Feuillet S, Rybojad M, Juillard C, Bergeron A, Dessirier V, Bouhidel F, Janin A, Bensussan A, Bagot M, Bouaziz JD. PLoS One. 2012;7(8):e43588.

B-cell activating factor levels in rheumatoid arthritis patients in response to - B-cell activating factor levels in rheumatoid arthritis patients in response to

Pyrpasopoulou A, Balaska E, Triantafyllou A, Anyfanti P, Aslanidis S, Douma S. J Interferon Cytokine Res. 2012 Jul;32(7):338-40.

Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host - Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host

Sarantopoulos S, Stevenson KE, Kim HT, Washel WS, Bhuiya NS, Cutler CS, Alyea EP, Ho VT, Soiffer RJ, Antin JH, Ritz J. Blood. 2011 Feb 17;117(7):2275-83.

Significant differences in B-cell subpopulations characterize patients with - Significant differences in B-cell subpopulations characterize patients with

Kuzmina Z, Greinix HT, Weigl R, Kormoczi U, Rottal A, Frantal S, Eder S, Pickl WF. Blood. 2011 Feb 17;117(7):2265-74.

Primary B-cell deficiencies reveal a link between human IL-17-producing CD4 - Primary B-cell deficiencies reveal a link between human IL-17-producing CD4

Barbosa RR, Silva SP, Silva SL, Melo AC, Pedro E, Barbosa MP, Pereira-Santos MC, Victorino RM, Sousa AE. PLoS One. 2011;6(8):e22848.

B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of - B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of

Thompson SA, Jones JL, Cox AL, Compston DA, Coles AJ. J Clin Immunol. 2010 Jan;30(1):99-105.

Peripheral blood B cell subset skewing is associated with altered cell cycling - Peripheral blood B cell subset skewing is associated with altered cell cycling

Sugalski JM, Rodriguez B, Moir S, Anthony DD. J Immunol. 2010 Sep 1;185(5):3019-27.